Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon
作者： Liv B. Gansmo , Stian Knappskog , Pål Romundstad , Kristian Hveem , Lars Vatten
DOI: 10.1002/IJC.29358
关键词:
摘要: © 2014 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC. This is an open access article under the terms Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided original work properly cited not used for commercial purposes
bibsys.no 参考文章(45)
Guoyuan Liu, Deke Jiang, Suqin Shen, Long Yu, Murine double minute 2promoter SNP309 polymorphism and prostate cancer risk: A meta-analysis International Journal of Urology. ,vol. 19, pp. 914- 920 ,(2012) , 10.1111/J.1442-2042.2012.03067.X
Stian Knappskog, Liv B Gansmo, Khadizha Dibirova, Andres Metspalu, Cezary Cybulski, Paolo Peterlongo, Lauri Aaltonen, Lars Vatten, Pål Romundstad, Kristian Hveem, Peter Devilee, Gareth D Evans, Dongxin Lin, Guy Van Camp, Vangelis G Manolopoulos, Ana Osorio, Lili Milani, Tayfun Ozcelik, Pierre Zalloua, Francis Mouzaya, Elena Bliznetz, Elena Balanovska, Elvira Pocheshkova, Vaidutis Kučinskas, Lubov Atramentova, Pagbajabyn Nymadawa, Konstantin Titov, Maria Lavryashina, Yuldash Yusupov, Natalia Bogdanova, Sergey Koshel, Jorge Zamora, David C Wedge, Deborah Charlesworth, Thilo Dörk, Oleg Balanovsky, Per E Lønning, None, Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649) Oncotarget. ,vol. 5, pp. 8223- 8234 ,(2014) , 10.18632/ONCOTARGET.1910
Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam, Jeno Gyuris, Kenneth W. Kinzler, Bert Vogelstein, Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Nature. ,vol. 362, pp. 857- 860 ,(1993) , 10.1038/362857A0
W. Porter, B. Saville, D. Hoivik, S. Safe, Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor Molecular Endocrinology. ,vol. 11, pp. 1569- 1580 ,(1997) , 10.1210/MEND.11.11.9916
Yan Wan, Wei Wu, Zhihua Yin, Peng Guan, Baosen Zhou, MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis BMC Cancer. ,vol. 11, pp. 208- 208 ,(2011) , 10.1186/1471-2407-11-208
D-W Wu, M-C Lee, J Wang, C-Y Chen, Y-W Cheng, H Lee, DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer Oncogene. ,vol. 33, pp. 1515- 1526 ,(2014) , 10.1038/ONC.2013.107
Cristina Albuquerque, Elvira R.M. Bakker, Wendy van Veelen, Ron Smits, Colorectal cancers choosing sides. Biochimica et Biophysica Acta. ,vol. 1816, pp. 219- 231 ,(2011) , 10.1016/J.BBCAN.2011.07.005
Fiona EM Paulin, Mary O'Neill, Gillian McGregor, Andrew Cassidy, Alison Ashfield, Clinton W Ali, Alastair J Munro, Lee Baker, Colin A Purdie, David P Lane, Alastair M Thompson, MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism BMC Cancer. ,vol. 8, pp. 281- 281 ,(2008) , 10.1186/1471-2407-8-281
G. L Bond, C. Menin, R. Bertorelle, P. Alhopuro, L. A Aaltonen, A. J Levine, MDM2 SNP309 Accelerates colorectal tumour formation in women Journal of Medical Genetics. ,vol. 43, pp. 950- 952 ,(2006) , 10.1136/JMG.2006.043539
Xian-Hua Gui, Li-Xin Qiu, Hai-Feng Zhang, De-Ping Zhang, Wen-Zhao Zhong, Jin Li, Yong-Long Xiao, MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians. European Journal of Cancer. ,vol. 45, pp. 2023- 2026 ,(2009) , 10.1016/J.EJCA.2009.02.002